Background To mitigate the effects of COVID-19, a vaccine is urgently needed. BBV152 is a
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …

Zika virus (ZIKV) is a mosquito-borne flavivirus that causes asymptomatic infection or presents
only mild symptoms in majority of those infected. However, vaccination for ZIKV is a public …

Background. Enteric fever caused by Salmonella Typhi remains a major public health
problem in developing countries. Typbar-TCV is a single-dose typhoid Vi polysaccharide–tetanus …

Background We report the clinical efficacy against COVID-19 infection of BBV152, a whole
virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …

Background BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine (3 μg or 6 μg)
formulated with a toll-like receptor 7/8 agonist molecule (IMDG) adsorbed to alum (Algel). We …

The COVID-19 pandemic is a global health crisis that poses a great challenge to the public
health system of affected countries. Safe and effective vaccines are needed to overcome this …

We report the development and evaluation of safety and immunogenicity of a whole virion
inactivated (WVI) SARS-CoV-2 vaccine (BBV152), adjuvanted with aluminum hydroxide gel (…

The availability of a safe and effective vaccine would be the eventual measure to deal with
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) threat. Here, we have …

Phospholipase D (PLD) is activated in mammalian cells in response to a variety of growth
factors and may play a role in cell proliferation. Lysophosphatidic acid (LPA) is a bioactive …

This is a comprehensive report on immunogenicity of COVAXIN ® booster dose against
ancestral and Variants of Concern (VOCs) up to 12 months. It is well known that neutralizing …